🇺🇸 FDA
Pipeline program

alpha 1H, Placebo product for Alpha1H

HP002-001

Phase 2 small_molecule active

Quick answer

alpha 1H, Placebo product for Alpha1H for Non-muscle invasive bladder cancer awaiting transurethral surgery is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Non-muscle invasive bladder cancer awaiting transurethral surgery
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials